Short-term diabetes decreases ischemia reperfusion-induced arrhythmia: the effect of alpha-2 blocker yohimbine and glibenclamide

This study examined the effect of yohimbine alone and in combination with glibenclamide on ischemia and reperfusioninduced arrhythmias in diabetes. Six minutes of ischemia were produced in 1-week diabetic rats by ligation of the left coronary artery and 6 min of reperfusion were produced by releasing the artery. | Turkish Journal of Biology Turk J Biol (2016) 40: 899-905 © TÜBİTAK doi: Research Article Short-term diabetes decreases ischemia reperfusion-induced arrhythmia: the effect of alpha-2 blocker yohimbine and glibenclamide 1, 2 1 1 Ömer BOZDOĞAN *, Salih Tunç KAYA , Selçuk YAŞAR , Erçin Çağdas BAŞ , 1 1 1 Oğulcan Talat ÖZARSLAN , Didem EKŞİOGLU , Firdevs ERİM 1 Department of Biology, Faculty of Science and Arts, Abant İzzet Baysal University, Gölköy, Bolu, Turkey 2 Department of Biology, Faculty of Science and Arts, Düzce University, Konuralp, Düzce, Turkey Received: Accepted/Published Online: Final Version: Abstract: This study examined the effect of yohimbine alone and in combination with glibenclamide on ischemia and reperfusioninduced arrhythmias in diabetes. Six minutes of ischemia were produced in 1-week diabetic rats by ligation of the left coronary artery, and 6 min of reperfusion were produced by releasing the artery. A dose of 5 mg/kg of yohimbine and glibenclamide was administered for 7 days prior to the coronary ligation. The blood pressure, heart rate, and arrhythmia were determined from the recorded ECG during the 6 min of ischemia and reperfusion and then compared using a one-way ANOVA statistical program and the chi-square test. The score of arrhythmia calculated from the type and duration of arrhythmia decreased in the diabetic rats ( ± in control, ± in diabetes group). The arrhythmia score returned to the control value in the rats that were given a combination of yohimbine and glibenclamide (3 ± ). Yohimbine is used in the treatment of erectile dysfunction; glibenclamide is used as an antidiabetic drug in diabetic patients and may be a risk factor in the increase of ischemia reperfusion-induced arrhythmias. Key words: Ischemia, reperfusion, arrhythmia, diabetes, glibenclamide, yohimbine 1. Introduction Ischemia that occurs .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.